
Link Pharma Chem Ltd Valuation Shifts Amidst Market Downturn
2026-11-18 08:01:39Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a sharp decline in its share price and deteriorating financial metrics, raising questions about its price attractiveness relative to peers and historical benchmarks.
Read More
Link Pharma Chem Ltd Valuation Shifts to Fair Amidst Steep Price Decline
2026-10-29 08:00:25Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a challenging market environment and deteriorating financial metrics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read More
Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns
2026-10-23 08:00:45Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite persistent headwinds reflected in its financial performance and market returns, the stock’s price-to-book value and other valuation metrics suggest a potential reappraisal of its price attractiveness relative to peers and historical benchmarks.
Read More
Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns
2026-10-06 08:00:29Link Pharma Chem Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade despite persistent operational challenges and a micro-cap status. This article analyses the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to its historical averages and peer group, providing investors with a comprehensive view of its price attractiveness and underlying risks.
Read More
Link Pharma Chem Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-09-21 08:00:26Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite ongoing operational challenges reflected in its financial metrics, the stock’s price-to-book value and other valuation multiples suggest a potentially compelling entry point for investors willing to navigate the risks inherent in this segment.
Read More
Link Pharma Chem Ltd Valuation Shifts to Fair Amidst Volatile Market Performance
2026-08-25 08:00:30Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen its valuation grade downgraded from attractive to fair, reflecting a notable shift in price attractiveness despite a recent uptick in its share price. This change comes amid a backdrop of challenging financial metrics and a mixed performance relative to the broader market and peers.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2026 | Source : BSENewspaper publication of Unaudited Financial Results of the Company for Quarter and Half year ended September 30 2026 in Business standard (English Edition) and Loksatta (Gujarati Edition).
Unaudited Financial Results Of The Board Meeting Held On 3Rd November 2026
03-Nov-2026 | Source : BSEUnaudited Financial results of the Board meeting held on 3rd November 2026
Board Meeting Outcome for Board Meeting Outcome Of Board Meeting Held On 3Rd November 2026
03-Nov-2026 | Source : BSEBoard meeting outcome of Board Meeting held on 3rd November 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available